LDS/Medical Tests/Fibrinogen Degradation Products (DR-70®)

Fibrinogen Degradation Products (DR-70®)

Colorectal cancer (CRC) has decreased over the last four decades; however, it is still the second-leading cause of cancer-related death in the United States. There has been an established link between fibrinogen degradation products (FDP) and cancer. The DR-70 test measures fibrin and fibrinogen degradation products for monitoring CRC patients. This measurement detects fragments D and E along with the D-dimer that is the normal end product of fibrin cleavage by plasmin. Normal healthy individuals produce minimal amounts of FDP, but plasmin and thrombin are over-released from cancer cells which consequently increase levels. Approximately 50% of patients treated for CRC will have disease recurrence. Most FDP assays available are specific for a single FDP component. DR-70 measurement gives a larger spectrum of components. Notably, FDP can be measured in urine from bladder cancer, plasma from lung cancer, or serum from other cancers; however, serum is the specimen for this particular assay. This assay should be used in conjunction with the full clinical picture or as a monitoring aid instead of a diagnosis because some patients with cancers other than the colon can have elevated results.

  • As an aid in diagnosis and treatment of colorectal cancer
  • Monitoring patients who have been diagnosed previously with colorectal cancer

Increased in:

  • Gastro Intestinal Disease
  • Colon Cancer
  • Lung Cancer
  • Liver Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Cervical Cancer
  • Gall Bladder Cancer
  • Pancreas Cancer
  • Gastric Cancer


0-1.4 µg/ml
 

 

ELISA, Immunoassay.

Serum collected in serum separated tubes (SST).

Stability

  • Ambient: 48 hours
  • Refrigerated: 1 week
  • Frozen: 3 months
CEA, Cancer antigen 19-9 (CA 19-9), Mismatch Repair by IHC, KRAS Mutation Detection, BRAF Mutation Detection, HNPCC/Lynch Syndrome, Familial Adenomatous Polyposis (APC) Sequencing, Septin 9 (SEPT9), Methylated DNA Detection, Circulating Tumor Cell Count (Cell Search™).
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login